Hyoscyamine Therapeutic Applications and Guidelines
Dosage and Administration
- The maximum daily dose of hyoscyamine is 1.5 mg, according to the guideline society Praxis Medical Insights 1
- Hyoscyamine 0.125 mg PO/ODT/SL every 4 hours as needed (maximum 1.5 mg/day) is a second-line option for managing excessive secretions in palliative care patients, as recommended by Praxis Medical Insights 1
Palliative Care
- Hyoscyamine is used as an anticholinergic agent in malignant bowel obstruction when other measures fail, as stated by the National Comprehensive Cancer Network 3
- Administration routes for hyoscyamine in palliative care include rectal, transdermal, subcutaneous, or intravenous when the oral route is not feasible, according to the National Comprehensive Cancer Network 3
- Hyoscyamine is considered as part of pharmacologic management in malignant bowel obstruction alongside other anticholinergics, such as scopolamine and glycopyrrolate, as recommended by the National Comprehensive Cancer Network 3
Patient Monitoring and Safety
- Patients taking hyoscyamine should be monitored for typical anticholinergic side effects, including dry mouth, urinary retention, constipation, and blurred vision, as advised by Praxis Medical Insights 1
- In elderly or post-stroke patients, hyoscyamine may cause more central nervous system effects compared to glycopyrrolate, which does not cross the blood-brain barrier, according to Praxis Medical Insights 1
Special Patient Populations
- Hyoscyamine can be used as an antispasmodic for chronic abdominal pain in hypermobile Ehlers-Danlos syndrome and related conditions, as stated by Clinical Gastroenterology and Hepatology 2